AcrAB Multidrug Efflux Pump Is Associated with Reduced Levels of Susceptibility to Tigecycline (GAR-936) in Proteus mirabilis

Gapped BLAST and PSI-BLAST: a new generation of protein database search programs

Altschul, S. (1997) · Nucleic Acids Research · doi:10.1093/nar/25.17.3389 · Cited by 73,302 · see citing works

Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically

Ferraro, M. J. (2000) · Cited by 16,875 · see citing works

National Committee for Clinical Laboratory Standards

Bruck, E. (1980) · PEDIATRICS · doi:10.1542/peds.65.1.187 · Cited by 14,736 · see citing works

REPLICA PLATING AND INDIRECT SELECTION OF BACTERIAL MUTANTS

Lederberg, J., & Lederberg, E. M. (1952) · Journal of Bacteriology · doi:10.1128/jb.63.3.399-406.1952 · Cited by 1,371 · see citing works

Multidrug efflux pumps of gram-negative bacteria

Nikaido, H. (1996) · Journal of Bacteriology · doi:10.1128/jb.178.20.5853-5859.1996 · Cited by 1,095 · see citing works

AcrAB efflux pump plays a major role in the antibiotic resistance phenotype of Escherichia coli multiple-antibiotic-resistance (Mar) mutants

Okusu, H., Ma, D., & Nikaido, H. (1996) · Journal of Bacteriology · doi:10.1128/jb.178.1.306-308.1996 · Cited by 818 · see citing works

In Vitro and In Vivo Antibacterial Activities of a Novel Glycylcycline, the 9- t -Butylglycylamido Derivative of Minocycline (GAR-936)

Petersen, P. J., Jacobus, N. V., Weiss, W. J., Sum, P., & TESTA, R. T. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.4.738 · Cited by 413 · see citing works

Evidence that TolC is required for functioning of the Mar/AcrAB efflux pump of Escherichia coli

Fralick, J. A. (1996) · Journal of Bacteriology · doi:10.1128/jb.178.19.5803-5805.1996 · Cited by 409 · see citing works

Antibiotic efflux pumps

Françoise Van Bambeke, A., Balzi, E., & Tulkens, P. M. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(00)00291-4 · Cited by 404 · see citing works

Overexpression ofmarA, soxS, oracrABproduces resistance to triclosan in laboratory and clinical strains ofEscherichia coli

McMurry, L. M., Oethinger, M. D., & Levy, S. B. (1998) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.1998.tb13905.x · Cited by 346 · see citing works

Efflux pumps and drug resistance in Gram-negative bacteria

Ma, D., Cook, D. N., Hearst, J. E., & Nikaido, H. (1994) · Trends in Microbiology · doi:10.1016/0966-842x(94)90654-8 · Cited by 282 · see citing works

Antimicrobial activity and spectrum of the new glycylcycline, GAR-936 tested against 1,203 recent clinical bacterial isolates

Gales, A. C., & Jones, R. N. (2000) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(99)00092-9 · Cited by 189 · see citing works

Expression of Pseudomonas aeruginosa Multidrug Efflux Pumps MexA-MexB-OprM and MexC-MexD-OprJ in a Multidrug-Sensitive Escherichia coli Strain

Srikumar, R., Kon, T., Gotoh, N., & Poole, K. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.1.65 · Cited by 184 · see citing works

Synthesis and structure-activity relationship of novel glycylcycline derivatives leading to the discovery of GAR-936

Sum, P., & Petersen, P. J. (1999) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(99)00216-4 · Cited by 173 · see citing works

Balancing the drug-resistance equation

Levy, S. B. (1994) · Trends in Microbiology · doi:10.1016/0966-842x(94)90607-6 · Cited by 148 · see citing works

The acrAB homolog of Haemophilus influenzae codes for a functional multidrug efflux pump

Sánchez, L., Pan, W., Viñas, M., & Nikaido, H. (1997) · Journal of Bacteriology · doi:10.1128/jb.179.21.6855-6857.1997 · Cited by 143 · see citing works

Evidence for an Efflux Pump Mediating Multiple Antibiotic Resistance in Salmonella enterica Serovar Typhimurium

Piddock, L. J. V., White, D. G., Gensberg, K., Pumbwe, L., & Griggs, D. J. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.11.3118-3121.2000 · Cited by 137 · see citing works

High-Level Fluoroquinolone-Resistant Clinical Isolates of Escherichia coli Overproduce Multidrug Efflux Protein AcrA

Mazzariol, A., Tokue, Y., Kanegawa, T. M., Cornaglia, G., & Nikaido, H. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.12.3441-3443.2000 · Cited by 124 · see citing works

Gene expression response to misfolded protein as a screen for soluble recombinant protein

Lesley, S. A., Graziano, J., Cho, C. Y., Knuth, M. W., & Klock, H. E. (2002) · Protein Engineering Design and Selection · doi:10.1093/protein/15.2.153 · Cited by 113 · see citing works

Epidemiology of tetracycline-resistance determinants

Roberts, M. C. (1994) · Trends in Microbiology · doi:10.1016/0966-842x(94)90610-6 · Cited by 110 · see citing works

In Vitro Activities of the Glycylcycline GAR-936 against Gram-Positive Bacteria

Boucher, H. W., Wennersten, C. B., & Eliopoulos, G. M. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.8.2225-2229.2000 · Cited by 98 · see citing works

Antipneumococcal Activities of GAR-936 (a New Glycylcycline) Compared to Those of Nine Other Agents against Penicillin-Susceptible and -Resistant Pneumococci

Hoellman, D. B., Pankuch, G. A., Jacobs, M. R., & Appelbaum, P. C. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.4.1085-1088.2000 · Cited by 65 · see citing works

Resistance to Methotrexate Due to AcrAB-Dependent Export from Escherichia coli

Kopytek, S., Dyer, J. C. D., Knapp, G. S., & Hu, J. C. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.11.3210-3212.2000 · Cited by 42 · see citing works

Extrachromosomal resistance in Gram-negative organisms: the evolution of β-lactamase

Jacoby, G. A. (1994) · Trends in Microbiology · doi:10.1016/0966-842x(94)90611-4 · Cited by 35 · see citing works

Increase in MICs of ciprofloxacin in vivo in two closely related clinical isolates of Enterobacter cloacae

Linde, H. ‐., Notka, F., Irtenkauf, C., Decker, J., Wild, J., Niller, H. H., Heisig, P., & Lehn, N. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/49.4.625 · Cited by 33 · see citing works

Mechanisms of Antibiotic Resistance

Munita, J. M., & Arias, C. A. (2016) · Microbiology Spectrum · doi:10.1128/microbiolspec.vmbf-0016-2015 · Cited by 2,782 · see citing works

The Challenge of Efflux-Mediated Antibiotic Resistance in Gram-Negative Bacteria

Li, X.-Z., Plésiat, P., & Nikaido, H. (2015) · Clinical Microbiology Reviews · doi:10.1128/cmr.00117-14 · Cited by 1,648 · see citing works

Multidrug-resistance efflux pumps ? not just for resistance

Piddock, L. J. V. (2006) · Nature Reviews Microbiology · doi:10.1038/nrmicro1464 · Cited by 1,523 · see citing works

Clinically Relevant Chromosomally Encoded Multidrug Resistance Efflux Pumps in Bacteria

Piddock, L. J. V. (2006) · Clinical Microbiology Reviews · doi:10.1128/cmr.19.2.382-402.2006 · Cited by 1,231 · see citing works

Efflux-mediated antimicrobial resistance

Poole, K. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki171 · Cited by 1,082 · see citing works

Antimicrobial Resistance and Virulence: a Successful or Deleterious Association in the Bacterial World?

Beceiro, A., Tomás, M., & Bou, G. (2013) · Clinical Microbiology Reviews · doi:10.1128/cmr.00059-12 · Cited by 1,078 · see citing works

Efflux-Mediated Drug Resistance in Bacteria

Li, X.-Z., & Nikaido, H. (2009) · Drugs · doi:10.2165/11317030-000000000-00000 · Cited by 976 · see citing works

Adaptive and Mutational Resistance: Role of Porins and Efflux Pumps in Drug Resistance

Fernández, L., & Hancock, R. E. W. (2012) · Clinical Microbiology Reviews · doi:10.1128/cmr.00043-12 · Cited by 905 · see citing works

Efflux-Mediated Drug Resistance in Bacteria

Li, X.-Z., & Nikaido, H. (2004) · Drugs · doi:10.2165/00003495-200464020-00004 · Cited by 803 · see citing works

Tetracycline Antibiotics and ResistancePreprint

Grossman, T. H. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a025387 · Cited by 737 · see citing works

The role of antibiotics and antibiotic resistance in nature

Aminov, R. I. (2009) · Environmental Microbiology · doi:10.1111/j.1462-2920.2009.01972.x · Cited by 689 · see citing works

Efflux-mediated multiresistance in Gram-negative bacteria

Poole, K. (2004) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2004.00763.x · Cited by 612 · see citing works

Bacterial resistance to antibiotics: Active efflux and reduced uptake

Kumar, A., & Schweizer, H. P. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2005.04.004 · Cited by 537 · see citing works

Mechanisms of antibiotic resistance

Munita, J. M., & Arias, C. A. (2016) · Virulence Mechanisms of Bacterial Pathogens · doi:10.1128/9781555819286.ch17 · Cited by 421 · see citing works

AdeIJK, a Resistance-Nodulation-Cell Division Pump Effluxing Multiple Antibiotics in Acinetobacter baumannii

Damier-Piolle, L., Magnet, S., Brémont, S., Lambert, T., & Courvalin, P. M. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00732-07 · Cited by 356 · see citing works

Treatment of infections caused by multidrug-resistant Gram-negative bacteria: report of the British Society for Antimicrobial Chemotherapy/Healthcare Infection Society/British Infection Association Joint Working Party†

Hawkey, P. M., Warren, R. E., Livermore, D. M., McNulty, C. A. M., Enoch, D., Otter, J. A., & Wilson, A. P. R. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dky027 · Cited by 331 · see citing works

Tigecycline

Pankey, G. A. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki248 · Cited by 299 · see citing works

Tigecycline: A Critical Analysis

Stein, G. E., & Craig, W. A. (2006) · Clinical Infectious Diseases · doi:10.1086/505494 · Cited by 295 · see citing works

Update on prevalence and mechanisms of resistance to linezolid, tigecycline and daptomycin in enterococci in Europe: Towards a common nomenclature

Bender, J. K., Cattoir, V., Hegstad, K., Sadowy, E., Coque, T. M., Westh, H., Hammerum, A. M., Schaffer, K., Burns, K., Murchan, S., et al. (2018) · Drug Resistance Updates · doi:10.1016/j.drup.2018.10.002 · Cited by 281 · see citing works

Tigecycline Efflux as a Mechanism for Nonsusceptibility in Acinetobacter baumannii

Peleg, A. Y., Adams, J. M., & Paterson, D. L. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01198-06 · Cited by 257 · see citing works

Acinetobacter baumannii bloodstream infection while receiving tigecycline: a cautionary report

Peleg, A. Y., Potoski, B. A., Rea, R. S., Adams, J. M., Sethi, J., Capitano, B., Husain, S., Kwak, E. J., Bhat, S. V., & Paterson, D. L. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl441 · Cited by 248 · see citing works

AdeABC multidrug efflux pump is associated with decreased susceptibility to tigecycline in Acinetobacter calcoaceticus–Acinetobacter baumannii complex

Ruzin, A. V., Keeney, D. R., & Bradford, P. A. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm058 · Cited by 238 · see citing works

Structure, Assembly, and Function of Tripartite Efflux and Type 1 Secretion Systems in Gram-Negative Bacteria

Alav, I., Kobylka, J., Kuth, M. S., Pos, K. M., Picard, M., Blair, J. M. A., & Bavro, V. N. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.1c00055 · Cited by 234 · see citing works

A Novel MATE Family Efflux Pump Contributes to the Reduced Susceptibility of Laboratory-Derived Staphylococcus aureus Mutants to Tigecycline

McAleese, F., Petersen, P. J., Ruzin, A. V., Dunman, P. M., Murphy, E., Projan, S. J., & Bradford, P. A. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.5.1865-1871.2005 · Cited by 233 · see citing works

Tigecycline: A New Glycylcycline for Treatment of Serious Infections

Noskin, G. A. (2005) · Clinical Infectious Diseases · doi:10.1086/431672 · Cited by 224 · see citing works

The Development of Third-Generation Tetracycline Antibiotics and New Perspectives

Rusu, A., & Buta, L. E. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13122085 · Cited by 221 · see citing works

Functional, biophysical, and structural bases for antibacterial activity of tigecycline

Olson, M. W., Ruzin, A., Feyfant, E., Rush, T. S., O'Connell, J., & Bradford, P. A. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01499-05 · Cited by 207 · see citing works

In vitro activity of tigecycline against 6792 Gram-negative and Gram-positive clinical isolates from the global Tigecycline Evaluation and Surveillance Trial (TEST Program, 2004)

Hoban, D. J., Bouchillon, S. K., Johnson, B., Johnson, J. L., & Dowzicky, M. J. (2005) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2005.06.001 · Cited by 201 · see citing works

Influence of Transcriptional Activator RamA on Expression of Multidrug Efflux Pump AcrAB and Tigecycline Susceptibility in Klebsiella pneumoniae

Ruzin, A. V., Visalli, M. A., Keeney, D. R., & Bradford, P. A. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.3.1017-1022.2005 · Cited by 203 · see citing works

Tigecycline: First of a New Class of Antimicrobial Agents

Rose, W. E., & Rybak, M. J. (2006) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.26.8.1099 · Cited by 196 · see citing works

Interaction of antibacterial compounds with RND efflux pumps in Pseudomonas aeruginosa

Dreier, J., & Ruggerone, P. (2015) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.00660 · Cited by 190 · see citing works

Tigecycline for the treatment of multidrug-resistant Enterobacteriaceae: a systematic review of the evidence from microbiological and clinical studies

Kelesidis, T., Karageorgopoulos, D. E., Kelesidis, I., & Falagas, M. E. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn311 · Cited by 184 · see citing works

Tigecycline: an update

Stein, G. E., & Babinchak, T. (2013) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2012.12.004 · Cited by 183 · see citing works

The emergence of clinical resistance to tigecycline

Sun, Y., Cai, Y., Liu, X., Bai, N., Liang, B., & Wang, R. (2012) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2012.09.005 · Cited by 182 · see citing works

Newer antibacterial drugs for a new century

Devasahayam, G., Scheld, W. M., & Hoffman, P. S. (2010) · Expert Opinion on Investigational Drugs · doi:10.1517/13543780903505092 · Cited by 155 · see citing works

MarA-mediated overexpression of the AcrAB efflux pump results in decreased susceptibility to tigecycline in Escherichia coli

Keeney, D. R., Ruzin, A. V., McAleese, F., Murphy, E., & Bradford, P. A. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm397 · Cited by 155 · see citing works

In Vitro Activity of Eravacycline against Carbapenem-Resistant Enterobacteriaceae and Acinetobacter baumannii

Livermore, D. M., Mushtaq, S., Warner, M., & Woodford, N. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00436-16 · Cited by 152 · see citing works

Tigecycline: A glycylcycline antimicrobial agent

Doan, T.-L., Fung, H. B., Mehta, D., & Riska, P. F. (2006) · Clinical Therapeutics · doi:10.1016/j.clinthera.2006.08.011 · Cited by 152 · see citing works

Biological counterstrike: antibiotic resistance mechanisms of Gram-positive cocci

Woodford, N. (2005) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2005.01140.x · Cited by 138 · see citing works

Genomics of KPC-Producing Klebsiella pneumoniae Sequence Type 512 Clone Highlights the Role of RamR and Ribosomal S10 Protein Mutations in Conferring Tigecycline Resistance

Villa, L., Feudi, C., Fortini, D., García-Fernández, A., & Carattoli, A. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01803-13 · Cited by 136 · see citing works

Differential contribution of AcrAB and OqxAB efflux pumps to multidrug resistance and virulence in Klebsiella pneumoniae

Bialek-Davenet, S., Lavigne, J., Guyot, K., Mayer, N., Tournebize, R., Brisse, S., Leflon‐Guibout, V., & Nicolas-Chanoine, M.-H. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku340 · Cited by 136 · see citing works

Colistin and tigecycline resistance in carbapenemase-producing Gram-negative bacteria: emerging resistance mechanisms and detection methods

Sekyere, J. O., Govinden, U., Bester, L. A., & Essack, S. Y. (2016) · Journal of Applied Microbiology · doi:10.1111/jam.13169 · Cited by 134 · see citing works

In Vitro Activity of Tigecycline against Isolates from Patients Enrolled in Phase 3 Clinical Trials of Treatment for Complicated Skin and Skin‐Structure Infections and Complicated Intra‐Abdominal Infections

Bradford, P. A., Weaver‐Sands, D. T., & Petersen, P. J. (2005) · Clinical Infectious Diseases · doi:10.1086/431673 · Cited by 133 · see citing works

Taking inventory: antibacterial agents currently at or beyond Phase 1

Bush, K., Macielag, M. J., & Weidner‐Wells, M. A. (2004) · Current Opinion in Microbiology · doi:10.1016/j.mib.2004.08.013 · Cited by 126 · see citing works

Tigecycline in combination with other antimicrobials: a review of in vitro, animal and case report studies

Entenza, J. M., & Moreillon, P. (2009) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2008.11.006 · Cited by 122 · see citing works

Effects of Efflux Transporter Genes on Susceptibility of Escherichia coli to Tigecycline (GAR-936)

Hirata, T., Saito, A., Nishino, K., Tamura, N., & Yamaguchi, A. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.6.2179-2184.2004 · Cited by 122 · see citing works

Presence of Tetracycline Resistance Determinants and Susceptibility to Tigecycline and Minocycline

Fluit, A. C., Florijn, A., Verhoef, J., & Milatović, D. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.4.1636-1638.2005 · Cited by 118 · see citing works

Multidrug resistant Acinetobacter baumannii--the role of AdeABC (RND family) efflux pump in resistance to antibiotics.

Wieczorek, P., Sacha, P., Hauschild, T., Żórawski, M., Krawczyk, M., & Tryniszewska, E. A. (2008) · Folia Histochemica et Cytobiologica · doi:10.2478/v10042-008-0056-x · Cited by 120 · see citing works

ramR Mutations in Clinical Isolates of Klebsiella pneumoniae with Reduced Susceptibility to Tigecycline

Hentschke, M., Wolters, M., Sobottka, I., Rohde, H., & Aepfelbacher, M. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00085-10 · Cited by 117 · see citing works

Phenotypic and Proteomic Characterization of Multiply Antibiotic-Resistant Variants of<i>Salmonella enterica</i>Serovar Typhimurium Selected Following Exposure to Disinfectants

Karatzas, K. A. G., Randall, L. P., Webber, M., Piddock, L. J. V., Humphrey, T. J., Woodward, M. J., & Coldham, N. G. (2008) · Applied and Environmental Microbiology · doi:10.1128/aem.01931-07 · Cited by 114 · see citing works

RamA, a Transcriptional Regulator, and AcrAB, an RND-Type Efflux Pump, are Associated with Decreased Susceptibility to Tigecycline in Enterobacter cloacae

Keeney, D. R., Ruzin, A. V., & Bradford, P. A. (2007) · Microbial Drug Resistance · doi:10.1089/mdr.2006.9990 · Cited by 111 · see citing works

Efflux systems in bacterial pathogens: An opportunity for therapeutic intervention? An industry view

Lynch, A. S. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.10.021 · Cited by 102 · see citing works

A Phase 3, open-label, non-comparative study of tigecycline in the treatment of patients with selected serious infections due to resistant Gram-negative organisms including Enterobacter species, Acinetobacter baumannii and Klebsiella pneumoniae

Vasilev, K. A., Reshedko, G., Orăsan, R., Sánchez, M., Teras, J., Babinchak, T., Dukart, G., Cooper, A., Dartois, N., Gandjini, H., et al. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn249 · Cited by 102 · see citing works

Tigecycline: a novel glycylcycline antibiotic

Zhanel, G. G., Karlowsky, J. A., Rubinstein, E., & Hoban, D. J. (2006) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.4.1.9 · Cited by 96 · see citing works

AcrAB Efflux Pump Plays a Role in Decreased Susceptibility to Tigecycline in Morganella morganii

Ruzin, A. V., Keeney, D. R., & Bradford, P. A. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.2.791-793.2005 · Cited by 93 · see citing works

Mechanisms and fitness costs of tigecycline resistance in Escherichia coli

Linkevičius, M., Sandegren, L., & Andersson, D. I. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt263 · Cited by 91 · see citing works

Current perspectives on tigecycline resistance in Enterobacteriaceae: susceptibility testing issues and mechanisms of resistance

Pournaras, S., Koumaki, V., Spanakis, N., Gennimata, V., & Tsakris, A. (2016) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2016.04.017 · Cited by 91 · see citing works

Extending the Potency and Lifespan of Antibiotics: Inhibitors of Gram-Negative Bacterial Efflux Pumps

Duffey, M., Jumde, R. P., da Costa, R. M. A., Ropponen, H., Blasco, B., & Piddock, L. J. V. (2024) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.4c00091 · Cited by 88 · see citing works

In vitro activity of tigecycline against 3989 Gram-negative and Gram-positive clinical isolates from the United States Tigecycline Evaluation and Surveillance Trial (TEST Program; 2004)

Bouchillon, S. K., Hoban, D. J., Johnson, B., Johnson, J. L., Hsiung, A., & Dowzicky, M. J. (2005) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2005.06.004 · Cited by 87 · see citing works

Tigecycline: A new glycylcycline antimicrobial agent

Kasbekar, N. (2006) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp050487 · Cited by 86 · see citing works

Staphylococci

Casey, A. L., Lambert, P. A., & Elliott, T. (2007) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(07)72175-1 · Cited by 85 · see citing works

Non-fermentative Gram-negative bacteria

Enoch, D., Birkett, C. I., & LUDLAM, H. A. (2007) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(07)72176-3 · Cited by 83 · see citing works

Correlation of the expression of acrB and the regulatory genes marA, soxS and ramA with antimicrobial resistance in clinical isolates of Klebsiella pneumoniae endemic to New York City

Bratu, S., Landman, D., George, A., Salvani, J., & Quale, J. M. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp186 · Cited by 81 · see citing works

Tigecycline

Rubinstein, E., & Vaughan, D. (2005) · Drugs · doi:10.2165/00003495-200565100-00002 · Cited by 78 · see citing works

In Vitro Selection of ramR and soxR Mutants Overexpressing Efflux Systems by Fluoroquinolones as Well as Cefoxitin in Klebsiella pneumoniae

Bialek-Davenet, S., Marcon, E., Leflon‐Guibout, V., Lavigne, J., Bert, F., Moreau, R., & Nicolas-Chanoine, M.-H. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00156-11 · Cited by 73 · see citing works

Activity of tigecycline tested against a global collection of Enterobacteriaceae, including tetracycline-resistant isolates

Fritsche, T. R., Strabala, P., Sader, H. S., Dowzicky, M. J., & Jones, R. N. (2005) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2005.06.010 · Cited by 73 · see citing works

Clinical Pharmacokinetics and Pharmacodynamics of Tigecycline

Barbour, A., Schmidt, S., Ma, B., Schiefelbein, L., Rand, K. H., Burkhardt, O., & Derendorf, H. (2009) · Clinical Pharmacokinetics · doi:10.2165/11317100-000000000-00000 · Cited by 71 · see citing works

Tigecycline

Frampton, J. E., & Curran, M. P. (2005) · Drugs · doi:10.2165/00003495-200565180-00008 · Cited by 66 · see citing works

Compound Efflux in Helicobacter pylori

Kutschke, A., & DeJonge, B. L. M. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.7.3009-3010.2005 · Cited by 64 · see citing works

Characterization and Sequence Analysis of Extended-Spectrum-β-Lactamase-Encoding Genes from Escherichia coli, Klebsiella pneumoniae , and Proteus mirabilis Isolates Collected during Tigecycline Phase 3 Clinical Trials

Jones, C. H., Tuckman, M., Keeney, D. R., Ruzin, A. V., & Bradford, P. A. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00883-08 · Cited by 61 · see citing works

Tigecycline: in-vitro performance as a predictor of clinical efficacy

Hawkey, P. M., & Finch, R. (2006) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2006.01621.x · Cited by 60 · see citing works

Tigecycline: An investigational glycylcycline antimicrobialwith activity against resistant gram-positive organisms

Garrison, M. W., Neumiller, J. J., & Setter, S. M. (2005) · Clinical Therapeutics · doi:10.1016/j.clinthera.2005.01.007 · Cited by 60 · see citing works

Cloning, Nucleotide Sequencing, and Analysis of the AcrAB-TolC Efflux Pump of Enterobacter cloacae and Determination of Its Involvement in Antibiotic Resistance in a Clinical Isolate

Pérez, A., Canle, D., Latasa, C., Poza, M., Beceiro, A., Tomás, M., Fernández, A., Mallo, S., Pérez‐Castro, S., Molina, F., et al. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00072-07 · Cited by 58 · see citing works

Efflux pumps of Gram-negative bacteria in brief

Auda, I. G., Salman, I. M. A., & Odah, J. G. (2020) · Gene Reports · doi:10.1016/j.genrep.2020.100666 · Cited by 57 · see citing works

Microbiology of drugs for treating multiply drug-resistant Gram-positive bacteria

Eliopoulos, G. M. (2009) · Journal of Infection · doi:10.1016/s0163-4453(09)60004-9 · Cited by 49 · see citing works

Tigecycline: a new glycylcycline antimicrobial

Townsend, M. L., POUND, M. W., & Drew, R. H. (2006) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2006.01188.x · Cited by 50 · see citing works

New advances in antibiotic development and discovery

Alekshun, M. N. (2005) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.14.2.117 · Cited by 50 · see citing works

Oritavancin and Tigecycline: Investigational Antimicrobials for Multidrug‐Resistant Bacteria

Guay, D. R. P. (2004) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.24.1.58.34808 · Cited by 47 · see citing works

Anaerobic choline metabolism in microcompartments promotes growth and swarming of P roteus mirabilis

Jameson, E., Fu, T., Brown, I. R., Paszkiewicz, K. H., Purdy, K. J., Frank, S., & Chen, Y. (2015) · Environmental Microbiology · doi:10.1111/1462-2920.13059 · Cited by 46 · see citing works

Induced tigecycline resistance inStreptococcus pneumoniaemutants reveals mutations in ribosomal proteins and rRNA

Lupien, A., Gingras, H., Leprohon, P., & Ouellette, M. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv211 · Cited by 46 · see citing works

Real-Time PCR and Statistical Analyses of acrAB and ramA Expression in Clinical Isolates of Klebsiella pneumoniae

Ruzin, A. V., Immermann, F. W., & Bradford, P. A. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00591-08 · Cited by 46 · see citing works

Combined ramR Mutation and Presence of a Tn 1721 -Associated tet (A) Variant in a Clinical Isolate of Salmonella enterica Serovar Hadar Resistant to Tigecycline

Hentschke, M., Christner, M., Sobottka, I., Aepfelbacher, M., & Rohde, H. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00993-09 · Cited by 45 · see citing works

Epidemiological MIC cut-off values for tigecycline calculated from Etest MIC values using normalized resistance interpretation

Kronvall, G., Karlsson, I., Walder, M., Sörberg, M., & Nilsson, L. E. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki489 · Cited by 43 · see citing works

RT-PCR and Statistical Analyses of adeABC Expression in Clinical Isolates of Acinetobacter calcoaceticus–Acinetobacter baumannii Complex

Ruzin, A. V., Immermann, F. W., & Bradford, P. A. (2010) · Microbial Drug Resistance · doi:10.1089/mdr.2009.0131 · Cited by 41 · see citing works

Developmental dynamics of antibiotic resistome in aerobic biofilm microbiota treating wastewater under stepwise increasing tigecycline concentrations

Tian, Z., Liu, R., Zhang, H., Yang, M., & Zhang, Y. (2019) · Environment International · doi:10.1016/j.envint.2019.105008 · Cited by 40 · see citing works

Contribution of AcrAB efflux pump to ciprofloxacin resistance in Klebsiella pneumoniae isolated from burn patients

Pakzad, I., Karin, M. Z., Taherikalani, M., Boustanshenas, M., & Lari, A. R. (2013) · Europe PMC (PubMed Central) · doi:10.3205/dgkh000215 · Cited by 37 · see citing works

Tigecycline challenge triggers sRNA production in Salmonella enterica serovar Typhimurium

Yu, J., & Schneiders, T. (2012) · BMC Microbiology · doi:10.1186/1471-2180-12-195 · Cited by 37 · see citing works

Tripartite efflux pumps of the RND superfamily: what did we learn from computational studies?

Athar, M., Gervasoni, S. I., Catte, A., Basciu, A., Malloci, G., Ruggerone, P., & Vargiu, A. V. (2023) · Microbiology · doi:10.1099/mic.0.001307 · Cited by 36 · see citing works

Current and novel antibiotics against resistant Gram-positive bacteria

Pérez, F. (2008) · Infection and Drug Resistance · doi:10.2147/idr.s3545 · Cited by 35 · see citing works

Tetracyclines, Glycylcyclines, and Chloramphenicol

Moffa, M. A., & Brook, I. (2015) · Elsevier eBooks · doi:10.1016/b978-1-4557-4801-3.00026-6 · Cited by 39 · see citing works

Analysis of the Topology of Vibrio cholerae NorM and Identification of Amino Acid Residues Involved in Norfloxacin Resistance

Singh, A. K., Haldar, R., Mandal, D., & Kundu, M. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00460-06 · Cited by 36 · see citing works

In vitro activities of tigecycline combined with other antimicrobials against multiresistant Gram-positive and Gram-negative pathogens

Vouillamoz, J., Moreillon, P., Giddey, M., & Entenza, J. M. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm459 · Cited by 36 · see citing works

The forgotten Gram-negative bacilli: What genetic determinants are telling us about the spread of antibiotic resistance

Gootz, T. D. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.11.006 · Cited by 35 · see citing works

Gene interaction network approach to elucidate the multidrug resistance mechanisms in the pathogenic bacterial strain Proteus mirabilis

Miryala, S. K., Anbarasu, A., & Ramaiah, S. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.29874 · Cited by 34 · see citing works

Antimicrobial activity against Streptococcus pneumoniae and Haemophilus influenzae collected globally between 2004 and 2008 as part of the Tigecycline Evaluation and Surveillance Trial

Darabi, A., Hocquet, D., & Dowzicky, M. J. (2010) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2009.12.009 · Cited by 34 · see citing works

Adaptation of Salmonella enterica Serovar Senftenberg to Linalool and Its Association with Antibiotic Resistance and Environmental Persistence

Kalily, E., Hollander, A., Korin, B., Cymerman, I., & Yaron, S. (2017) · Applied and Environmental Microbiology · doi:10.1128/aem.03398-16 · Cited by 32 · see citing works

In vitro activity of tigecycline against strains isolated from diabetic foot ulcers

Sotto, A., Bouziges, N., Jourdan, N., Richard, J.-L., & Lavigne, J.-P. (2007) · Pathologie Biologie · doi:10.1016/j.patbio.2007.07.003 · Cited by 31 · see citing works

Resistance trends and in vitro activity of tigecycline and 17 other antimicrobial agents against Gram-positive and Gram-negative organisms, including multidrug-resistant pathogens, in Germany

Study Group, Kresken, M., Becker, K., Seifert, H., Leitner, E., Körber-Irrgang, B., von Eiff, C., & Löschmann, P. A. (2011) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-011-1197-y · Cited by 30 · see citing works

In Vitro Activities of Tigecycline, Ertapenem, Isepamicin,and Other Antimicrobial Agents Against Clinically IsolatedOrganisms in Taiwan

Cheng, N.-C., Hsueh, P., Liu, Y.-C., Shyr, J.-M., Huang, W.-K., Teng, L., & Liu, C. (2005) · Microbial Drug Resistance · doi:10.1089/mdr.2005.11.330 · Cited by 30 · see citing works

Evaluation of tigecycline activity in clinical isolates among Indian medical centers

Manoharan, A., Chatterjee, S., Madhan, S., & Mathai, D. C. (2010) · Indian Journal of Pathology and Microbiology · doi:10.4103/0377-4929.72061 · Cited by 26 · see citing works

RamA, a Transcriptional Regulator, and AcrAB, an RND-Type Efflux Pump, are Associated with Decreased Susceptibility to Tigecycline in Enterobacter cloacae

Keeney, D. R., Ruzin, A. V., & Bradford, P. A. (2007) · Microbial Drug Resistance · doi:10.1089/mdr.2006.9990 · Cited by 111 · see citing works

AcrAB Efflux Pump Plays a Role in Decreased Susceptibility to Tigecycline in Morganella morganii

Ruzin, A. V., Keeney, D. R., & Bradford, P. A. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.2.791-793.2005 · Cited by 93 · see citing works

Tigecycline Efflux as a Mechanism for Nonsusceptibility in Acinetobacter baumannii

Peleg, A. Y., Adams, J. M., & Paterson, D. L. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01198-06 · Cited by 257 · see citing works

Efflux Pump AcrAB Confers Decreased Susceptibility to Piperacillin–Tazobactam and Ceftolozane–Tazobactam in Tigecycline-Non-Susceptible Klebsiella pneumoniae

Li, J., Xu, Q., Ogurek, S., Li, Z., Wang, P., Xie, Q., Sheng, Z.-K., & Wang, M. (2020) · Infection and Drug Resistance · doi:10.2147/idr.s279020 · Cited by 19 · see citing works

Roles of Salmonella multidrug efflux pumps in tigecycline resistance

Horiyama, T., Nikaido, E., Yamaguchi, A., & Nishino, K. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq421 · Cited by 35 · see citing works